Baker Bros. Advisors LP / AXSM
Baker Bros. Advisors LP’s Axsome Therapeutics Inc. Position
Does Baker Bros. Advisors LP own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 611.0K shares worth $25M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$25M
Q1 2022
Shares
611.0K
% of Portfolio
+0.15%
Quarters Held
13
position exited
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2022 | 611.0K | $25M | +0.15% |
| Q4 2021 | 611.0K | $23M | +0.11% |
| Q3 2021 | 539.1K | $18M | +0.08% |
| Q2 2021 | 539.1K | $36M | +0.16% |
| Q1 2021 | 628.4K | $36M | +0.15% |
| Q4 2020 | 778.8K | $63M | +0.24% |
| Q3 2020 | 959.8K | $68M | +0.27% |
| Q2 2020 | 1.01M | $83M | +0.37% |
| Q1 2020 | 889.8K | $52M | +0.32% |
| Q4 2019 | 829.8K | $86M | +0.46% |
| Q3 2019 | 772.3K | $16M | +0.11% |
| Q2 2019 | 772.3K | $20M | +0.14% |
| Q1 2019 | 1.20M | $17M | +0.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Baker Bros. Advisors LP’s full portfolio or all institutional holders of AXSM.